Why Biogen Stock Popped Today | The Motley Fool
Author Bio A Fool since 2019, Prospers writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, youll find him curling up with a good book or doing math. What happened? On Friday morning, Biogen (NASDAQ:BIIB) released an update regarding its Biologics License Application (BLA) for aducanumab as...
Paul Matteis Biologics License Application Wall Street Drug Administration Major Amendment Stifel Financial
Source: fool.com